跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 80 条关于
“teclistimab”
全部
80
临床试验
60
药物
1
机构
0
资讯
19
去年
J&J's TALVEY® Navigates Regulatory Hurdles for Multiple Myeloma Treatment
去年
Optimizing Treatment Strategies for Relapsed Multiple Myeloma: From CAR T-Cell Therapy to Novel Combinations
4年前
Teclistamab Shows Promise in Heavily Pretreated Multiple Myeloma
去年
Teclistamab Maintenance Therapy Shows Promise in Newly Diagnosed Multiple Myeloma
去年
Teclistamab Shows Sustained Efficacy in Relapsed/Refractory Multiple Myeloma
去年
Teclistamab Shows Promise as Frontline Therapy for Multiple Myeloma in Newly Diagnosed Patients
2年前
NHS Scotland Approves Elranatamab and Teclistamab for Relapsed/Refractory Multiple Myeloma
去年
Talquetamab and Teclistamab Combination Shows Promise in Relapsed/Refractory Multiple Myeloma
4年前
Bispecific Antibodies Teclistamab and Talquetamab Show Promise in Multiple Myeloma Treatment
去年
Real-World Data Highlight Teclistamab's Flexible Use in Relapsed/Refractory Multiple Myeloma
第 1 页,共 2 页
上一页
下一页